Loading live market data…

Damora Therapeutics, Inc.

NASDAQ:DMRA

$30.99 USD

$2.99 (10.68%)

Volume
0
Average Volume
542.57K
Market Capitalization
$1.91B
P/E Ratio
-0.17
Dividend Yield
0.00%
Price Target
$40.00
Year High
$38.33
Year Low
$2.45
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$22.48

NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)

9

NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)

2

AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)

$ 925

DMRA Estimated and Actual Revenue by Quarter

Get MSFT Insider Trade Alerts

DMRA Insider Trading History

Insider Name Title Date Transaction Cost Filing Date
Winslow Garrett officer: General Counsel 2026-07-03 M-Exempt 0 2026-07-07
Winslow Garrett officer: General Counsel 2026-07-06 S-Sale 29.98 2026-07-07
Winslow Garrett officer: General Counsel 2026-07-03 M-Exempt 0 2026-07-07
Burkavage Brian officer: SVP, Finance 2026-05-01 32 2026-05-08
Jarrett Jennifer director, officer: See Remarks 2026-03-30 A-Award 25.5 2026-04-01
Jarrett Jennifer director, officer: See Remarks 2026-03-30 A-Award 0 2026-04-01
Jarrett Jennifer 2026-03-30 0 2026-04-01
Winslow Garrett officer: General Counsel 2026-03-23 A-Award 23.05 2026-03-25
Turtle Cameron director 2026-03-23 A-Award 23.05 2026-03-25
Landsittel Michael director 2026-03-23 A-Award 23.05 2026-03-25
Fairmount Funds Management LLC director, 10 percent owner: 2026-03-23 A-Award 23.05 2026-03-25
CAIN CHRISTOPHER W. director 2026-03-23 A-Award 23.05 2026-03-25
Bruno Julianne director 2026-03-23 A-Award 23.05 2026-03-25
Turtle Cameron 2026-03-23 0 2026-03-25
Landsittel Michael 2026-03-23 0 2026-03-25